Aarti Industries Q4 FY26 Results: Revenue ₹2,422 Cr

Board approves audited FY26 numbers

Aarti Industries Limited (AIL) announced its consolidated financial results for the fourth quarter and full year ended March 31, 2026. The company said the audited results were approved by its Board of Directors at a meeting held on May 4, 2026. Management flagged a complex operating backdrop for global chemicals, particularly disruptions linked to geopolitical tensions in the Middle East. According to the company, these disruptions affected supply chains, logistics, and input costs across the industry during the quarter.

Q4 FY26 backdrop: supply chain stress and cost pressure

AIL said it navigated the quarter through proactive market diversification, stable demand across key segments, and disciplined execution of strategic priorities. The company highlighted its ability to redirect volumes dynamically and manage cost pressures as an important operational lever during disruptions. It also pointed to continuity planning around suppliers and logistics as the external environment remained volatile.

Two strategic global contracts expand long-term visibility

During the quarter, AIL announced two strategic global contracts aimed at strengthening long-term earnings visibility.

First, it announced a backward integration initiative with a leading global chemical company. AIL said this would transition the relationship into a more integrated, end-to-end manufacturing model. The company indicated a capital expenditure plan of about ₹200–250 crore to cater to requirements over the residual 15-year contract period.

Second, AIL disclosed a $150 million multi-year supply agreement with a global agrochemical innovator. The agreement is for a critical agrochemical intermediate used in crop protection formulations and extends through March 31, 2030. The company said this contract would not require significant incremental CAPEX.

Q4 FY26 financial performance: revenue down sequentially, EBITDA up

For Q4 FY26 on a consolidated basis, income from operations stood at ₹2,422 crore, compared with ₹2,492 crore in Q3 FY26. EBITDA came in at ₹342 crore versus ₹323 crore in the previous quarter, indicating sequential improvement in operating profit despite lower revenue.

The company also noted that the finance cost for the quarter included a revaluation loss of about ₹39 crore on its long-term foreign-currency loan, due to steep depreciation of the Indian rupee during the quarter. Profit after tax (PAT) stood at ₹137 crore, compared with ₹133 crore in Q3 FY26.

FY26 full-year highlights: double-digit growth across metrics

For the full year FY26, AIL reported revenue of ₹9,018 crore, reflecting 12% year-on-year growth, supported by stable domestic demand and strong export performance. EBITDA for FY26 was ₹1,172 crore, up 15% year-on-year, supported by volume growth and cost optimisation initiatives. PAT was ₹419 crore, registering 27% year-on-year growth.

CEO commentary: re-routing volumes and integration focus

CEO and Executive Director Suyog Kotecha said FY26 was shaped by heightened global volatility and macro uncertainty, with geopolitical developments and shifting trade dynamics affecting the chemical sector. He said the company focused on increasing market share, optimising spreads, and sustaining operating discipline. He added that AIL responded by rerouting volumes from disrupted regions to minimise the impact on overall performance, and that deeper integration and long-term partnerships were strengthening earnings visibility.

Recognition: Gallup Exceptional Workplace Award 2026

AIL said it was honoured with the 2026 Gallup Exceptional Workplace Award (GEWA) by Gallup. The company said it is among the first manufacturing companies in India to receive this recognition. Management linked the award to its emphasis on a high-performance, people-centric culture.

Outlook: cautious optimism, West Asia risks remain

The company said FY26-27 begins with cautious optimism, supported by improving capacity utilisation, strong order visibility through long-term contracts, and progress on growth and integration initiatives. At the same time, it highlighted that the situation in West Asia continues to pose risks to the availability of certain critical feedstocks and the placement of key products in the Middle East. AIL said it is working with suppliers and exploring alternate sourcing and placement avenues to ensure continuity of operations.

Additional disclosed data points from provided materials

Separately, an analyst note included in the provided material maintained an ADD recommendation on AIL with a target price of ₹467 per share. The note stated that revenue and EBITDA are expected to increase at a CAGR of 8% and 22% over FY25-28E, and referred to projects worth ₹2,300–2,500 crore (INR23–25bn) planned for commissioning over the next 15–18 months.

The same material also included quarter metrics presented in ₹ billion, which convert to ₹ crore as follows: revenue of INR 23.18bn equals ₹2,318 crore and EBITDA of INR 3.21bn equals ₹321 crore, with an EBITDA margin of 13.8% mentioned.

Key numbers at a glance

Why the update matters for investors

AIL’s Q4 FY26 result shows a divergence between revenue and profitability on a sequential basis, with EBITDA rising even as revenue dipped from Q3 FY26. The company’s commentary emphasised agility in managing supply and logistics disruptions, which is relevant given the quarter’s reference to Middle East-linked supply-chain issues. The two disclosed long-term contracts add duration to order visibility, with one contract extending to March 31, 2030 and another framed around a residual 15-year period, alongside a stated ₹200–250 crore capex plan for backward integration.

Conclusion

Aarti Industries closed FY26 with 12% revenue growth and improved profitability, while reporting a sequential pickup in Q4 EBITDA. The company enters FY26-27 with cautious optimism, supported by long-term contracts and improving capacity utilisation, while continuing to monitor West Asia-linked feedstock and placement risks.